Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-4,960
Closed -$13K 314
2020
Q2
$13K Hold
4,960
﹤0.01% 229
2020
Q1
$11K Hold
4,960
﹤0.01% 237
2019
Q4
$23K Hold
4,960
0.01% 200
2019
Q3
$23K Hold
4,960
0.01% 189
2019
Q2
$23K Hold
4,960
0.01% 188
2019
Q1
$21K Hold
4,960
0.01% 162
2018
Q4
$19K Sell
4,960
-3,425
-41% -$14.6K 0.01% 157
2018
Q3
$38K Hold
8,385
0.01% 118
2018
Q2
$39K Sell
8,385
-2,392
-22% -$14.1K 0.01% 124
2018
Q1
$78K Buy
10,777
+962
+10% +$6.62K 0.03% 94
2017
Q4
$63K Buy
+9,815
New +$62.8K 0.03% 105
2017
Q2
Sell
-900
Closed -$5K 296
2017
Q1
$5K Hold
900
﹤0.01% 254
2016
Q4
$4K Buy
+900
New +$4.86K ﹤0.01% 286

Other funds holding ABEV

Roble Belko & Company's ABEV Position: Q3 2020 in Review

Roble Belko & Company sold out of Ambev (ABEV) in Q3 2020, closing a stake of 4,960 shares — an estimated $13K sold.

Roble Belko & Company first reported a position in ABEV in Q4 2016 and held it in 13 quarters. The position peaked at $78K in Q1 2018. 267 funds tracked by Wall St. Rank hold ABEV as of Q3 2020.

  • Roble Belko & Company reported no remaining Ambev position as of Q3 2020 after selling out during the quarter.
  • Roble Belko & Company sold 4,960 Ambev shares in Q3 2020, an estimated $13K.
  • Roble Belko & Company first reported a position in Ambev in Q4 2016 and held it in 13 quarters.
  • Roble Belko & Company's Ambev position peaked at $78K in Q1 2018.
  • 267 funds tracked by Wall St. Rank held Ambev as of Q3 2020.

Based on Roble Belko & Company's 13F filing for Q3 2020, filed 10 Nov 2020.